News & Updates

Immune-mediated reactions predict survival in nivolumab-treated NSCLC patients
Immune-mediated reactions predict survival in nivolumab-treated NSCLC patients
18 Feb 2023

Several patients with nonsmall cell lung cancer (NSCLC) treated with nivolumab report developing immune-related adverse events (irAEs), primarily affecting the skin, lungs, and gastrointestinal system, according to a study.

Immune-mediated reactions predict survival in nivolumab-treated NSCLC patients
18 Feb 2023
Rising cases of community-acquired E. coli UTI in children a cause for concern
Rising cases of community-acquired E. coli UTI in children a cause for concern
18 Feb 2023

A recent study has found an increasing prevalence of community-acquired (CA) urinary tract infection (UTI) by emerging spectrum-β-lactamase-producing (ESBL) E. coli in children, with most isolates showing resistance to multiple drugs.

Rising cases of community-acquired E. coli UTI in children a cause for concern
18 Feb 2023
Endometrioma ups risk of failing antibiotic treatment for pelvic inflammatory disease
Endometrioma ups risk of failing antibiotic treatment for pelvic inflammatory disease
18 Feb 2023

Among women with pelvic inflammatory disease, the presence of endometrioma is associated with a lower likelihood of responding to antibiotic treatment and a higher risk of surgical intervention, according to a study.

Endometrioma ups risk of failing antibiotic treatment for pelvic inflammatory disease
18 Feb 2023
Treat childhood obesity promptly—AAP
Treat childhood obesity promptly—AAP
17 Feb 2023 byJairia Dela Cruz

Paediatricians and other healthcare providers should treat childhood obesity immediately and at the highest level of intensity appropriate for and available to children, according to the new guideline published by the American Academy of Pediatrics (AAP).

Treat childhood obesity promptly—AAP
17 Feb 2023
Counselling, pamphlets boost flu vaccine intake in SG
Counselling, pamphlets boost flu vaccine intake in SG
17 Feb 2023